Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
On Friday, RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company currently trading at $96.34, downgrading the stock from Outperform ...
A buying opportunity could have opened up for patient investors. The post 3 top blue-chip ASX 200 shares that look dirt cheap right now appeared first on The Motley Fool Australia.
Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.
Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a continuation of its share buy-back program, purchasing 2,500 shares on the previous day, adding to the 44,500 already ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...
LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...
Citi analyst Mathieu Chevrier maintained a Sell rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$255.00. The company’s shares closed last Wednesday at $235.10.
Morgans analyst Derek Jellinek downgraded Cochlear Limited (CHEOF – Research Report) to a Hold today and set a price target of A$290.50. The company’s shares closed last Friday at $205.54. According ...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The goal of this article is to teach you how to use price to earnings ratios (P/E ratios).
MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...